| 15 Fasciola gigantica: epidemiology, control, immunology and molecular biology TW Spithill, PM Smooker, D Bruce Fasciolosis 50 (2), 465-525, 1999 | 400 | 1999 |
| Antibiotic use in food animals worldwide, with a focus on Africa: Pluses and minuses TTH Van, Z Yidana, PM Smooker, PJ Coloe Journal of global antimicrobial resistance 20, 170-177, 2020 | 327 | 2020 |
| Bacterial Kinetics-Controlled Shape-Directed Biosynthesis of Silver Nanoplates Using Morganella psychrotolerans R Ramanathan, AP O’Mullane, RY Parikh, PM Smooker, SK Bhargava, ... Langmuir 27 (2), 714-719, 2011 | 210 | 2011 |
| Aqueous phase synthesis of copper nanoparticles: a link between heavy metal resistance and nanoparticle synthesis ability in bacterial systems R Ramanathan, MR Field, AP O'Mullane, PM Smooker, SK Bhargava, ... Nanoscale 5 (6), 2300-2306, 2013 | 200 | 2013 |
| Fasciolosis JP Dalton CABI, 2021 | 182 | 2021 |
| The sensitivity and specificity of two methods for detecting Fasciola infections in cattle N Anderson, TT Luong, NG Vo, KL Bui, PM Smooker, TW Spithill Veterinary Parasitology 83 (1), 15-24, 1999 | 172 | 1999 |
| Anisakis nematodes in fish and shellfish-from infection to allergies IE Aibinu, PM Smooker, AL Lopata International Journal for Parasitology: Parasites and Wildlife 9, 384-393, 2019 | 151 | 2019 |
| The antibiotic resistance characteristics of non-typhoidal Salmonella enterica isolated from food-producing animals, retail meat and humans in South East Asia TTH Van, HNK Nguyen, PM Smooker, PJ Coloe International Journal of Food Microbiology 154 (3), 98-106, 2012 | 146 | 2012 |
| Pre-existing immunity against vaccine vectors–friend or foe? M Saxena, TTH Van, FJ Baird, PJ Coloe, PM Smooker Microbiology 159 (Pt_1), 1-11, 2013 | 145 | 2013 |
| Evaluation of antigens of Fasciola gigantica as vaccines against tropical fasciolosis in cattle SE Estunningsih, PM Smooker, E Wiedosari, S Widjajanti, S Vaiano, ... International Journal for Parasitology 27 (11), 1419-1428, 1997 | 145 | 1997 |
| Immunological approaches for the control of fasciolosis TW Spithill, D Piedrafita, PM Smooker International Journal for Parasitology 27 (10), 1221-1235, 1997 | 123 | 1997 |
| Cloning and Expression of the Major SecretedCathepsin B-Like Protein from Juvenile Fasciola hepatica andAnalysis of Immunogenicity following Liver FlukeInfection RHP Law, PM Smooker, JA Irving, D Piedrafita, R Ponting, NJ Kennedy, ... Infection and immunity 71 (12), 6921-6932, 2003 | 120 | 2003 |
| Live-attenuated bacterial vectors: tools for vaccine and therapeutic agent delivery IYC Lin, TTH Van, PM Smooker Vaccines 3 (4), 940-972, 2015 | 119 | 2015 |
| 11 Development of Vaccines Against Fasciola hepatica TW Spithill, PM Smooker, JL Sexton, E Bozas, CA Morrison, J Creaney, ... CABI Publishing, 1999 | 106 | 1999 |
| Vaccination against fasciolosis by a multivalent vaccine of stage-specific antigens R Jayaraj, D Piedrafita, K Dynon, R Grams, TW Spithill, PM Smooker Veterinary Parasitology 160 (3-4), 230-236, 2009 | 99 | 2009 |
| Molecular characterization of antibiotic resistance in Pseudomonas and Aeromonas isolates from catfish of the Mekong Delta, Vietnam HNK Nguyen, TTH Van, HT Nguyen, PM Smooker, J Shimeta, PJ Coloe Veterinary Microbiology 171 (3-4), 397-405, 2014 | 95 | 2014 |
| The Evolution of Enzyme Specificity in Fasciola spp. JA Irving, TW Spithill, RN Pike, JC Whisstock, PM Smooker Journal of Molecular Evolution 57, 1-15, 2003 | 93 | 2003 |
| Cathepsin B proteases of flukes: the key to facilitating parasite control? PM Smooker, R Jayaraj, RN Pike, TW Spithill Trends in parasitology 26 (10), 506-514, 2010 | 87 | 2010 |
| A single amino acid substitution affects substrate specificity in cysteine proteinases from Fasciola hepatica PM Smooker, JC Whisstock, JA Irving, S Siyaguna, TW Spithill, RN Pike Protein Science 9 (12), 2567-2572, 2000 | 78 | 2000 |
| Differences between two clinical Staphylococcus capitis subspecies as revealed by biofilm, antibiotic resistance, and pulsed-field gel electrophoresis profiling B Cui, PM Smooker, DA Rouch, AJ Daley, MA Deighton Journal of clinical microbiology 51 (1), 9-14, 2013 | 71 | 2013 |
